Fresenius Medical Care AG (ETR:FME – Get Free Report) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of €37.03 ($40.25) and traded as high as €37.35 ($40.60). Fresenius Medical Care shares last traded at €35.36 ($38.43), with a volume of 732,943 shares trading hands.
Fresenius Medical Care Stock Performance
The stock’s fifty day moving average is €36.86 and its two-hundred day moving average is €37.03. The firm has a market capitalization of $10.54 billion, a price-to-earnings ratio of 19.54, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
See Also
- Five stocks we like better than Fresenius Medical Care
- Earnings Per Share Calculator: How to Calculate EPS
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Industrial Products Stocks Investing
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What Is WallStreetBets and What Stocks Are They Targeting?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.